Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    " April 17, 2013":" May 17, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Active, not recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
2 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
3 Completed Randomized Placebo-controlled Pilot Trial of Prebiotics+Glutamine in HIV Infection
Condition: HIV
Interventions: Dietary Supplement: Prebiotics+Glutamine;   Dietary Supplement: Placebo
4 Completed An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Condition: HIV-associated Lipodystrophy Syndrome
Interventions: Drug: GSK1265744B (sodium salt) containing 14C-GSK1265744B;   Drug: 150 mg GSK1265744B;   Drug: Placebo
5 Recruiting Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois
Condition: HIV Infections
Interventions: Behavioral: Correctional case management;   Behavioral: Transitional case management
6 Recruiting HIV Non-Occupational Post-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus
Intervention: Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)
7 Completed Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immunodeficiency Syndrome (AIDS)
Intervention: Other: Questionnaire
8 Enrolling by invitation The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling
Condition: HIV Infection
Intervention: Other: Self-Collected HPV Test
9 Recruiting Brief Intervention for Rural Women at High Risk for HIV/HCV
Conditions: Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
Intervention: Other: MI-based HIV Risk Reduction
10 Unknown  Immune Activation and Drug Absorption in HIV-Infected Patients
Condition: HIV Infection
Intervention: Drug: Rifampicin 600 mg
11 Active, not recruiting Therapeutic Vaccine for HIV
Conditions: HIV;   Therapeutic Vaccine
Interventions: Biological: rVSV;   Biological: IL-12 pDNA adjuvant;   Biological: HIV-Mag pDNA;   Drug: Placebo
12 Completed Trial to Improve Access to PMTCT Services and Reduce HIV Transmission From Mother to Child
Conditions: Mother-to-child Transmission of HIV;   Pregnancy
Interventions: Other: Enhanced CHW intervention;   Other: Standard of care
13 Completed Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV
Condition: HIV
Intervention: Behavioral: Aerobic and Strength Training Intervention
14 Completed Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder
Conditions: HIV;   Sexually Transmitted Infection;   Pregnancy
Interventions: Behavioral: STYLE Brazil;   Behavioral: Health Promotion
15 Active, not recruiting Monoclonal Antibody-based Multipurpose Microbicides
Conditions: HIV;   Sexually Transmitted Infections (STI)
16 Completed
Has Results
Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat
Condition: Human Immunodeficiency Virus Type 1 (HIV-1)
Interventions: Drug: Atazanavir;   Drug: Cobicistat;   Drug: Atazanavir/Cobicistat FDC
17 Recruiting Sustainable East Africa Research in Community Health
Conditions: HIV;   Tuberculosis;   Hypertension;   Diabetes;   Maternal Child Health;   Cost Effectiveness
Interventions: Other: Universal ART in a streamlined care model;   Other: Annual Community Health Campaigns;   Other: Targeted PrEP, Targeted testing, and Targeted care interventions;   Other: Baseline community-based HIV and multi-disease testing
18 Completed Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia
Condition: HIV
Intervention: Device: PrePex
19 Recruiting Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
Condition: HIV
Interventions: Biological: pSG2.HIVconsv DNA vaccine;   Biological: ChAdV63.HIVconsv booster vaccine;   Biological: MVA.HIVconsv booster vaccine;   Drug: CPHPC;   Other: Placebo
20 Active, not recruiting Kumasi Cohort Study
Condition: HIV
Intervention: Other: Virological monitoring

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years